精神分裂症严重结局患者抗精神病治疗药代动力学特征的遗传标记

Science and Innovations Pub Date : 2023-08-08 DOI:10.29235/1818-9857-2023-07-78-83

V. Obiedkov, I. Goloenko, O. Bokut, T. Dokukina, T. Golubeva, L. Tishkevich, A. Khodzhaev

{"title":"精神分裂症严重结局患者抗精神病治疗药代动力学特征的遗传标记","authors":"V. Obiedkov, I. Goloenko, O. Bokut, T. Dokukina, T. Golubeva, L. Tishkevich, A. Khodzhaev","doi":"10.29235/1818-9857-2023-07-78-83","DOIUrl":null,"url":null,"abstract":"The article analysed the relationships between genetic factors and resistance of patients with a severe outcome of schizophrenia to ongoing drug treatment, which is necessary to understand the reasons for the formation of such an endophenotype.","PeriodicalId":250051,"journal":{"name":"Science and Innovations","volume":"69 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Genetic markers of pharmacokinetic features in patients with a severe outcome of schizophrenia, resistant to antipsychotic therapy\",\"authors\":\"V. Obiedkov, I. Goloenko, O. Bokut, T. Dokukina, T. Golubeva, L. Tishkevich, A. Khodzhaev\",\"doi\":\"10.29235/1818-9857-2023-07-78-83\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The article analysed the relationships between genetic factors and resistance of patients with a severe outcome of schizophrenia to ongoing drug treatment, which is necessary to understand the reasons for the formation of such an endophenotype.\",\"PeriodicalId\":250051,\"journal\":{\"name\":\"Science and Innovations\",\"volume\":\"69 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-08-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Science and Innovations\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.29235/1818-9857-2023-07-78-83\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Science and Innovations","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.29235/1818-9857-2023-07-78-83","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

本文分析了遗传因素与精神分裂症严重结局患者对持续药物治疗的耐药性之间的关系，这对于了解这种内表型形成的原因是必要的。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Genetic markers of pharmacokinetic features in patients with a severe outcome of schizophrenia, resistant to antipsychotic therapy

The article analysed the relationships between genetic factors and resistance of patients with a severe outcome of schizophrenia to ongoing drug treatment, which is necessary to understand the reasons for the formation of such an endophenotype.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Science and Innovations

自引率

0.00%

发文量